1 2330 95 TWELVE WEEKS OF YOGA FOR CHRONIC NONSPECIFIC LOWER BACK PAIN: A META-ANALYSIS. OBJECTIVES: TO INVESTIGATE THE OVERALL EFFECTS OF 12 WEEKS OF YOGA PRACTICE ON CHRONIC NONSPECIFIC LOWER BACK PAIN. METHODS: PUBMED, EMBASE, PSYCINFO, WEB OF SCIENCE, AND THE COCHRANE LIBRARY DATABASES WERE SEARCHED FROM INCEPTION TO FEBRUARY 9, 2019, AND SIX RANDOMIZED CONTROLLED TRIALS WERE SELECTED FOR THIS META-ANALYSIS. RESULTS: THE POOLED FIXED-EFFECT SIZE OF SIX TRIALS SHOWED THAT 12 WEEKS OF YOGA PROGRAMS COULD SIGNIFICANTLY REDUCE CHRONIC NONSPECIFIC LOWER BACK PAIN BY 0.41 WITHIN THE TRIALS (STANDARDIZED MEAN DIFFERENCE; 95% CONFIDENCE INTERVAL: -0.58 TO -0.23; P < .0001). SUBGROUP ANALYSES ALSO SHOWED THAT SIGNIFICANT PAIN REDUCTION WAS RELATED TO TYPE OF YOGA, LENGTH OF SESSION, STUDY QUALITY, AND TIMING OF PAIN ASSESSMENT. CONCLUSIONS: THESE FINDINGS REVEAL THAT 12 WEEKS OF YOGA CAN HELP ALLEVIATE PAIN, AND YOGA PROGRAMS SHOULD TAKE INTO ACCOUNT THE SUBGROUP FACTORS TO INCREASE INDIVIDUALS' RELIEF FROM CHRONIC NONSPECIFIC LOWER BACK PAIN. 2020 2 2589 31 YOGA FOR LOW BACK PAIN: A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. IT HAS BEEN SUGGESTED THAT YOGA HAS A POSITIVE EFFECT ON LOW BACK PAIN AND FUNCTION. THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A TREATMENT OPTION FOR LOW BACK PAIN. SEVEN DATABASES WERE SEARCHED FROM THEIR INCEPTION TO MARCH 2011. RANDOMIZED CLINICAL TRIALS WERE CONSIDERED IF THEY INVESTIGATED YOGA IN PATIENTS WITH LOW BACK PAIN AND IF THEY ASSESSED PAIN AS AN OUTCOME MEASURE. THE SELECTION OF STUDIES, DATA EXTRACTION AND VALIDATION WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. SEVEN RANDOMIZED CONTROLLED CLINICAL TRIALS (RCTS) MET THE INCLUSION CRITERIA. THEIR METHODOLOGICAL QUALITY RANGED BETWEEN 2 AND 4 ON THE JADAD SCALE. FIVE RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN LOW BACK PAIN THAN USUAL CARE, EDUCATION OR CONVENTIONAL THERAPEUTIC EXERCISES. TWO RCTS SHOWED NO BETWEEN-GROUP DIFFERENCES. IT IS CONCLUDED THAT YOGA HAS THE POTENTIAL TO ALLEVIATE LOW BACK PAIN. HOWEVER, ANY DEFINITIVE CLAIMS SHOULD BE TREATED WITH CAUTION. 2011 3 1055 31 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. [PURPOSE] THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF CHRONIC NECK PAIN. [SUBJECTS AND METHODS] FIVE ELECTRONIC DATABASES WERE SEARCHED TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA INTERVENTION ON CHRONIC NECK PAIN. THE TRIALS WERE PUBLISHED IN THE ENGLISH LANGUAGE BETWEEN JANUARY 1966 AND DECEMBER 2015. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE QUALITY OF THE TRIALS. [RESULTS] THREE TRIALS WERE IDENTIFIED AND INCLUDED IN THIS REVIEW. A CRITICAL APPRAISAL WAS PERFORMED ON THE TRIALS, AND THE RESULT INDICATED A HIGH RISK OF BIAS. A NARRATIVE DESCRIPTION WAS PROCESSED BECAUSE OF THE SMALL NUMBER OF RCTS. NECK PAIN INTENSITY AND FUNCTIONAL DISABILITY WERE SIGNIFICANTLY LOWER IN THE YOGA GROUPS THAN IN THE CONTROL GROUPS. [CONCLUSION] EVIDENCE FROM THE 3 RANDOMLY CONTROLLED TRIALS SHOWS THAT YOGA MAY BE BENEFICIAL FOR CHRONIC NECK PAIN. THE LOW-QUALITY RESULT OF THE CRITICAL APPRAISAL AND THE SMALL NUMBER OF TRIALS SUGGEST THAT HIGH-QUALITY RCTS ARE REQUIRED TO EXAMINE FURTHER THE EFFECTS OF YOGA INTERVENTION ON CHRONIC NECK PAIN RELIEF. 2016 4 1044 26 EFFECTS OF YOGA INTERVENTIONS ON PAIN AND PAIN-ASSOCIATED DISABILITY: A META-ANALYSIS. UNLABELLED: WE SEARCHED DATABASES FOR CONTROLLED CLINICAL STUDIES, AND PERFORMED A META-ANALYSIS ON THE EFFECTIVENESS OF YOGA INTERVENTIONS ON PAIN AND ASSOCIATED DISABILITY. FIVE RANDOMIZED STUDIES REPORTED SINGLE-BLINDING AND HAD A HIGHER METHODOLOGICAL QUALITY; 7 STUDIES WERE RANDOMIZED BUT NOT BLINDED AND HAD MODERATE QUALITY; AND 4 NONRANDOMIZED STUDIES HAD LOW QUALITY. IN 6 STUDIES, YOGA WAS USED TO TREAT PATIENTS WITH BACK PAIN; IN 2 STUDIES TO TREAT RHEUMATOID ARTHRITIS; IN 2 STUDIES TO TREAT PATIENTS WITH HEADACHE/MIGRAINE; AND 6 STUDIES ENROLLED INDIVIDUALS FOR OTHER INDICATIONS. ALL STUDIES REPORTED POSITIVE EFFECTS IN FAVOR OF THE YOGA INTERVENTIONS. WITH RESPECT TO PAIN, A RANDOM EFFECT META-ANALYSIS ESTIMATED THE OVERALL TREATMENT EFFECT AT SMD = -.74 (CI: -.97; -.52, P < .0001), AND AN OVERALL TREATMENT EFFECT AT SMD = -.79 (CI: -1.02; -.56, P < .0001) FOR PAIN-RELATED DISABILITY. DESPITE SOME LIMITATIONS, THERE IS EVIDENCE THAT YOGA MAY BE USEFUL FOR SEVERAL PAIN-ASSOCIATED DISORDERS. MOREOVER, THERE ARE HINTS THAT EVEN SHORT-TERM INTERVENTIONS MIGHT BE EFFECTIVE. NEVERTHELESS, LARGE-SCALE FURTHER STUDIES HAVE TO IDENTIFY WHICH PATIENTS MAY BENEFIT FROM THE RESPECTIVE INTERVENTIONS. PERSPECTIVE: THIS META-ANALYSIS SUGGESTS THAT YOGA IS A USEFUL SUPPLEMENTARY APPROACH WITH MODERATE EFFECT SIZES ON PAIN AND ASSOCIATED DISABILITY. 2012 5 2540 35 YOGA FOR ANXIETY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. YOGA HAS BECOME A POPULAR APPROACH TO IMPROVE EMOTIONAL HEALTH. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS AND SAFETY OF YOGA FOR ANXIETY. MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, PSYCINFO, AND INDMED WERE SEARCHED THROUGH OCTOBER 2016 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA FOR INDIVIDUALS WITH ANXIETY DISORDERS OR ELEVATED LEVELS OF ANXIETY. THE PRIMARY OUTCOMES WERE ANXIETY AND REMISSION RATES, AND SECONDARY OUTCOMES WERE DEPRESSION, QUALITY OF LIFE, AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. EIGHT RCTS WITH 319 PARTICIPANTS (MEAN AGE: 30.0-38.5 YEARS) WERE INCLUDED. RISK OF SELECTION BIAS WAS UNCLEAR FOR MOST RCTS. META-ANALYSES REVEALED EVIDENCE FOR SMALL SHORT-TERM EFFECTS OF YOGA ON ANXIETY COMPARED TO NO TREATMENT (STANDARDIZED MEAN DIFFERENCE [SMD] = -0.43; 95% CONFIDENCE INTERVAL [CI] = -0.74, -0.11; P = .008), AND LARGE EFFECTS COMPARED TO ACTIVE COMPARATORS (SMD = -0.86; 95% CI = -1.56, -0.15; P = .02). SMALL EFFECTS ON DEPRESSION WERE FOUND COMPARED TO NO TREATMENT (SMD = -0.35; 95% CI = -0.66, -0.04; P = .03). EFFECTS WERE ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS. NO EFFECTS WERE FOUND FOR PATIENTS WITH ANXIETY DISORDERS DIAGNOSED BY DIAGNOSTIC AND STATISTICAL MANUAL CRITERIA, ONLY FOR PATIENTS DIAGNOSED BY OTHER METHODS, AND FOR INDIVIDUALS WITH ELEVATED LEVELS OF ANXIETY WITHOUT A FORMAL DIAGNOSIS. ONLY THREE RCTS REPORTED SAFETY-RELATED DATA BUT THESE INDICATED THAT YOGA WAS NOT ASSOCIATED WITH INCREASED INJURIES. IN CONCLUSION, YOGA MIGHT BE AN EFFECTIVE AND SAFE INTERVENTION FOR INDIVIDUALS WITH ELEVATED LEVELS OF ANXIETY. THERE WAS INCONCLUSIVE EVIDENCE FOR EFFECTS OF YOGA IN ANXIETY DISORDERS. MORE HIGH-QUALITY STUDIES ARE NEEDED AND ARE WARRANTED GIVEN THESE PRELIMINARY FINDINGS AND PLAUSIBLE MECHANISMS OF ACTION. 2018 6 2607 43 YOGA FOR PRENATAL DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: PRENATAL DEPRESSION CAN NEGATIVELY AFFECT THE PHYSICAL AND MENTAL HEALTH OF BOTH MOTHER AND FETUS. THE AIM OF THIS STUDY WAS TO DETERMINE THE EFFECTIVENESS OF YOGA AS AN INTERVENTION IN THE MANAGEMENT OF PRENATAL DEPRESSION. METHODS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS) WAS CONDUCTED BY SEARCHING PUBMED, EMBASE, THE COCHRANE LIBRARY AND PSYCINFO FROM ALL RETRIEVED ARTICLES DESCRIBING SUCH TRIALS UP TO JULY 2014. RESULTS: SIX RCTS WERE IDENTIFIED IN THE SYSTEMATIC SEARCH. THE SAMPLE CONSISTED OF 375 PREGNANT WOMEN, MOST OF WHOM WERE BETWEEN 20 AND 40 YEARS OF AGE. THE DIAGNOSES OF DEPRESSION WERE DETERMINED BY THEIR SCORES ON STRUCTURED CLINICAL INTERVIEW FOR DSM-IV AND THE CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE. WHEN COMPARED WITH COMPARISON GROUPS (E.G., STANDARD PRENATAL CARE, STANDARD ANTENATAL EXERCISES, SOCIAL SUPPORT, ETC.), THE LEVEL OF DEPRESSION STATISTICALLY SIGNIFICANTLY REDUCED IN YOGA GROUPS (STANDARDIZED MEAN DIFFERENCE [SMD], -0.59; 95% CONFIDENCE INTERVAL [CI], -0.94 TO -0.25; P = 0.0007). ONE SUBGROUP ANALYSIS REVEALED THAT BOTH THE LEVELS OF DEPRESSIVE SYMPTOMS IN PRENATALLY DEPRESSED WOMEN (SMD, -0.46; CI, -0.90 TO -0.03; P = 0.04) AND NON-DEPRESSED WOMEN (SMD, -0.87; CI, -1.22 TO -0.52; P < 0.00001) WERE STATISTICALLY SIGNIFICANTLY LOWER IN YOGA GROUP THAN THAT IN CONTROL GROUP. THERE WERE TWO KINDS OF YOGA: THE PHYSICAL-EXERCISE-BASED YOGA AND INTEGRATED YOGA, WHICH, BESIDES PHYSICAL EXERCISES, INCLUDED PRANAYAMA, MEDITATION OR DEEP RELAXATION. THEREFORE, THE OTHER SUBGROUP ANALYSIS WAS CONDUCTED TO ESTIMATE EFFECTS OF THE TWO KINDS OF YOGA ON PRENATAL DEPRESSION. THE RESULTS SHOWED THAT THE LEVEL OF DEPRESSION WAS SIGNIFICANTLY DECREASED IN THE INTEGRATED YOGA GROUP (SMD, -0.79; CI, -1.07 TO -0.51; P < 0.00001) BUT NOT SIGNIFICANTLY REDUCED IN PHYSICAL-EXERCISE-BASED YOGA GROUP (SMD, -0.41; CI, -1.01 TO -0.18; P = 0.17). CONCLUSIONS: PRENATAL YOGA INTERVENTION IN PREGNANT WOMEN MAY BE EFFECTIVE IN PARTLY REDUCING DEPRESSIVE SYMPTOMS. 2015 7 2110 41 THE EFFECT OF YOGA ON SLEEP QUALITY AND INSOMNIA IN WOMEN WITH SLEEP PROBLEMS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: TO EXAMINE THE EFFECTIVENESS AND SAFETY OF YOGA OF WOMEN WITH SLEEP PROBLEMS BY PERFORMING A SYSTEMATIC REVIEW AND META-ANALYSIS. METHODS: MEDLINE/PUBMED, CLINICALKEY, SCIENCEDIRECT, EMBASE, PSYCINFO, AND THE COCHRANE LIBRARY WERE SEARCHED THROUGHOUT THE MONTH OF JUNE, 2019. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA GROUPS WITH CONTROL GROUPS IN WOMEN WITH SLEEP PROBLEMS WERE INCLUDED. TWO REVIEWERS INDEPENDENTLY EVALUATED RISK OF BIAS BY USING THE RISK OF BIAS TOOL SUGGESTED BY THE COCHRANE COLLABORATION FOR PROGRAMMING AND CONDUCTING SYSTEMATIC REVIEWS AND META-ANALYSES. THE MAIN OUTCOME MEASURE WAS SLEEP QUALITY OR THE SEVERITY OF INSOMNIA, WHICH WAS MEASURED USING SUBJECTIVE INSTRUMENTS, SUCH AS THE PITTSBURGH SLEEP QUALITY INDEX (PSQI), INSOMNIA SEVERITY INDEX (ISI), OR OBJECTIVE INSTRUMENTS SUCH AS POLYSOMNOGRAPHY, ACTIGRAPHY, AND SAFETY OF THE INTERVENTION. FOR EACH OUTCOME, A STANDARDIZED MEAN DIFFERENCE (SMD) AND CONFIDENCE INTERVALS (CIS) OF 95% WERE DETERMINED. RESULTS: NINETEEN STUDIES IN THIS SYSTEMATIC REVIEW INCLUDED 1832 PARTICIPANTS. THE META-ANALYSIS OF THE COMBINED DATA CONDUCTED ACCORDING TO COMPREHENSIVE META-ANALYSIS SHOWED A SIGNIFICANT IMPROVEMENT IN SLEEP (SMD = - 0.327, 95% CI = - 0.506 TO - 0.148, P < 0.001). META-ANALYSES REVEALED POSITIVE EFFECTS OF YOGA USING PSQI SCORES IN 16 RANDOMIZED CONTROL TRIALS (RCTS), COMPARED WITH THE CONTROL GROUP IN IMPROVING SLEEP QUALITY AMONG WOMEN USING PSQI (SMD = - 0.54; 95% CI = - 0.89 TO - 0.19; P = 0.003). HOWEVER, THREE RCTS REVEALED NO EFFECTS OF YOGA COMPARED TO THE CONTROL GROUP IN REDUCING INSOMNIA AMONG WOMEN USING ISI (SMD = - 0.13; 95% CI = - 0.74 TO 0.48; P = 0.69). SEVEN RCTS REVEALED NO EVIDENCE FOR EFFECTS OF YOGA COMPARED WITH THE CONTROL GROUP IN IMPROVING SLEEP QUALITY FOR WOMEN WITH BREAST CANCER USING PSQI (SMD = - 0.15; 95% CI = - 0.31 TO 0.01; P = 0.5). FOUR RCTS REVEALED NO EVIDENCE FOR THE EFFECTS OF YOGA COMPARED WITH THE CONTROL GROUP IN IMPROVING THE SLEEP QUALITY FOR PERI/POSTMENOPAUSAL WOMEN USING PSQI (SMD = - 0.31; 95% CI = - 0.95 TO 0.33; P = 0.34). YOGA WAS NOT ASSOCIATED WITH ANY SERIOUS ADVERSE EVENTS. DISCUSSION: THIS SYSTEMATIC REVIEW AND META-ANALYSIS DEMONSTRATED THAT YOGA INTERVENTION IN WOMEN CAN BE BENEFICIAL WHEN COMPARED TO NON-ACTIVE CONTROL CONDITIONS IN TERM OF MANAGING SLEEP PROBLEMS. THE MODERATOR ANALYSES SUGGEST THAT PARTICIPANTS IN THE NON-BREAST CANCER SUBGROUP AND PARTICIPANTS IN THE NON-PERI/POSTMENOPAUSAL SUBGROUP WERE ASSOCIATED WITH GREATER BENEFITS, WITH A DIRECT CORRELATION OF TOTAL CLASS TIME WITH QUALITY OF SLEEP AMONG OTHER RELATED BENEFITS. 2020 8 2518 52 YOGA COMPARED TO NON-EXERCISE OR PHYSICAL THERAPY EXERCISE ON PAIN, DISABILITY, AND QUALITY OF LIFE FOR PATIENTS WITH CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: CHRONIC LOW BACK PAIN (CLBP) IS A COMMON AND OFTEN DISABLING MUSCULOSKELETAL CONDITION. YOGA HAS BEEN PROVEN TO BE AN EFFECTIVE THERAPY FOR CHRONIC LOW BACK PAIN. HOWEVER, THERE ARE STILL CONTROVERSIES ABOUT THE EFFECTS OF YOGA AT DIFFERENT FOLLOW-UP PERIODS AND COMPARED WITH OTHER PHYSICAL THERAPY EXERCISES. OBJECTIVE: TO CRITICALLY COMPARE THE EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, QUALITY OF LIFE WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION), PHYSICAL THERAPY EXERCISE. METHODS: THIS STUDY WAS REGISTERED IN PROSPERO, AND THE REGISTRATION NUMBER WAS CRD42020159865. RANDOMIZED CONTROLLED TRIALS (RCTS) OF ONLINE DATABASES INCLUDED PUBMED, WEB OF SCIENCE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, EMBASE WHICH EVALUATED EFFECTS OF YOGA FOR PATIENTS WITH CHRONIC LOW BACK PAIN ON PAIN, DISABILITY, AND QUALITY OF LIFE WERE SEARCHED FROM INCEPTION TIME TO NOVEMBER 1, 2019. STUDIES WERE ELIGIBLE IF THEY ASSESSED AT LEAST ONE IMPORTANT OUTCOME, NAMELY PAIN, BACK-SPECIFIC DISABILITY, QUALITY OF LIFE. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE METHODOLOGICAL QUALITY OF INCLUDED RANDOMIZED CONTROLLED TRIALS. THE CONTINUOUS OUTCOMES WERE ANALYZED BY CALCULATING THE MEAN DIFFERENCE (MD) OR STANDARDIZED MEAN DIFFERENCE (SMD) WITH 95% CONFIDENCE INTERVALS (CI) ACCORDING TO WHETHER COMBINING OUTCOMES MEASURED ON DIFFERENT SCALES OR NOT. RESULTS: A TOTAL OF 18 RANDOMIZED CONTROLLED TRIALS WERE INCLUDED IN THIS META-ANALYSIS. YOGA COULD SIGNIFICANTLY REDUCE PAIN AT 4 TO 8 WEEKS (MD = -0.83, 95% CI = -1.19 TO -0.48, P<0.00001, I2 = 0%), 3 MONTHS (MD = -0.43, 95% CI = -0.64 TO -0.23, P<0.0001, I2 = 0%), 6 TO 7 MONTHS (MD = -0.56, 95% CI = -1.02 TO -0.11, P = 0.02, I2 = 50%), AND WAS NOT SIGNIFICANT IN 12 MONTHS (MD = -0.52, 95% CI = -1.64 TO 0.59, P = 0.36, I2 = 87%) COMPARED WITH NON-EXERCISE. YOGA WAS BETTER THAN NON-EXERCISE ON DISABILITY AT 4 TO 8 WEEKS (SMD = -0.30, 95% CI = -0.51 TO -0.10, P = 0.003, I2 = 0%), 3 MONTHS (SMD = -0.31, 95% CI = -0.45 TO -0.18, P<0.00001, I2 = 30%), 6 MONTHS (SMD = -0.38, 95% CI = -0.53 TO -0.23, P<0.00001, I2 = 0%), 12 MONTHS (SMD = -0.33, 95% CI = -0.54 TO -0.12, P = 0.002, I2 = 9%). THERE WAS NO SIGNIFICANT DIFFERENCE ON PAIN, DISABILITY COMPARED WITH PHYSICAL THERAPY EXERCISE GROUP. FURTHERMORE, IT SUGGESTED THAT THERE WAS A NON-SIGNIFICANT DIFFERENCE ON PHYSICAL AND MENTAL QUALITY OF LIFE BETWEEN YOGA AND ANY OTHER INTERVENTIONS. CONCLUSION: THIS META-ANALYSIS PROVIDED EVIDENCE FROM VERY LOW TO MODERATE INVESTIGATING THE EFFECTIVENESS OF YOGA FOR CHRONIC LOW BACK PAIN PATIENTS AT DIFFERENT TIME POINTS. YOGA MIGHT DECREASE PAIN FROM SHORT TERM TO INTERMEDIATE TERM AND IMPROVE FUNCTIONAL DISABILITY STATUS FROM SHORT TERM TO LONG TERM COMPARED WITH NON-EXERCISE (E.G. USUAL CARE, EDUCATION). YOGA HAD THE SAME EFFECT ON PAIN AND DISABILITY AS ANY OTHER EXERCISE OR PHYSICAL THERAPY. YOGA MIGHT NOT IMPROVE THE PHYSICAL AND MENTAL QUALITY OF LIFE BASED ON THE RESULT OF A MERGING. 2020 9 1740 28 PHYSICAL AND PSYCHOSOCIAL BENEFITS OF YOGA IN CANCER PATIENTS AND SURVIVORS, A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: THIS STUDY AIMED TO SYSTEMATICALLY REVIEW THE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) AND TO CONDUCT A META-ANALYSIS OF THE EFFECTS OF YOGA ON PHYSICAL AND PSYCHOSOCIAL OUTCOMES IN CANCER PATIENTS AND SURVIVORS. METHODS: A SYSTEMATIC LITERATURE SEARCH IN TEN DATABASES WAS CONDUCTED IN NOVEMBER 2011. STUDIES WERE INCLUDED IF THEY HAD AN RCT DESIGN, FOCUSED ON CANCER PATIENTS OR SURVIVORS, INCLUDED PHYSICAL POSTURES IN THE YOGA PROGRAM, COMPARED YOGA WITH A NON-EXERCISE OR WAITLIST CONTROL GROUP, AND EVALUATED PHYSICAL AND/OR PSYCHOSOCIAL OUTCOMES. TWO RESEARCHERS INDEPENDENTLY RATED THE QUALITY OF THE INCLUDED RCTS, AND HIGH QUALITY WAS DEFINED AS >50% OF THE TOTAL POSSIBLE SCORE. EFFECT SIZES (COHEN'S D) WERE CALCULATED FOR OUTCOMES STUDIED IN MORE THAN THREE STUDIES AMONG PATIENTS WITH BREAST CANCER USING MEANS AND STANDARD DEVIATIONS OF POST-TEST SCORES OF THE INTERVENTION AND CONTROL GROUPS. RESULTS: SIXTEEN PUBLICATIONS OF 13 RCTS MET THE INCLUSION CRITERIA, OF WHICH ONE INCLUDED PATIENTS WITH LYMPHOMAS AND THE OTHERS FOCUSED ON PATIENTS WITH BREAST CANCER. THE MEDIAN QUALITY SCORE WAS 67% (RANGE: 22-89%). THE INCLUDED STUDIES EVALUATED 23 PHYSICAL AND 20 PSYCHOSOCIAL OUTCOMES. OF THE OUTCOMES STUDIED IN MORE THAN THREE STUDIES AMONG PATIENTS WITH BREAST CANCER, WE FOUND LARGE REDUCTIONS IN DISTRESS, ANXIETY, AND DEPRESSION (D = -0.69 TO -0.75), MODERATE REDUCTIONS IN FATIGUE (D = -0.51), MODERATE INCREASES IN GENERAL QUALITY OF LIFE, EMOTIONAL FUNCTION AND SOCIAL FUNCTION (D = 0.33 TO 0.49), AND A SMALL INCREASE IN FUNCTIONAL WELL-BEING (D = 0.31). EFFECTS ON PHYSICAL FUNCTION AND SLEEP WERE SMALL AND NOT SIGNIFICANT. CONCLUSION: YOGA APPEARED TO BE A FEASIBLE INTERVENTION AND BENEFICIAL EFFECTS ON SEVERAL PHYSICAL AND PSYCHOSOCIAL SYMPTOMS WERE REPORTED. IN PATIENTS WITH BREAST CANCER, EFFECT SIZE ON FUNCTIONAL WELL-BEING WAS SMALL, AND THEY WERE MODERATE TO LARGE FOR PSYCHOSOCIAL OUTCOMES. 2012 10 1299 37 HATHA YOGA FOR ACUTE, CHRONIC AND/OR TREATMENT-RESISTANT MOOD AND ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: THE AIM OF THIS STUDY WAS TO SYSTEMATICALLY INVESTIGATE THE EFFECTIVENESS OF HATHA YOGA IN TREATING ACUTE, CHRONIC AND/OR TREATMENT-RESISTANT MOOD AND ANXIETY DISORDERS. METHODS: MEDLINE, COCHRANE LIBRARY, CURRENT CONTROLLED TRIALS, CLINICAL TRIALS.GOV, NHR CENTRE FOR REVIEWS AND DISSEMINATION, PSYCINFO AND CINAHL WERE SEARCHED THROUGH JUNE 2018. RANDOMIZED CONTROLLED TRIALS WITH PATIENTS WITH MOOD AND ANXIETY DISORDERS WERE INCLUDED. MAIN OUTCOMES WERE CONTINUOUS MEASURES OF SEVERITY OF MOOD AND ANXIETY SYMPTOMS. COHEN'S D WAS CALCULATED AS A MEASURE OF EFFECT SIZE. META-ANALYSES USING A RANDOM EFFECTS MODEL WAS APPLIED TO ESTIMATE DIRECT COMPARISONS BETWEEN YOGA AND CONTROL CONDITIONS FOR DEPRESSION AND ANXIETY OUTCOMES. PUBLICATION BIAS WAS VISUALLY INSPECTED USING FUNNEL PLOTS. RESULTS: EIGHTEEN STUDIES WERE FOUND, FOURTEEN IN ACUTE PATIENTS AND FOUR IN CHRONIC PATIENTS. MOST STUDIES WERE OF LOW QUALITY. FOR DEPRESSION OUTCOMES, HATHA YOGA DID NOT SHOW A SIGNIFICANT EFFECT WHEN COMPARED TO TREATMENT AS USUAL, AN OVERALL EFFECT SIZE OF COHEN'S D -0.64 (95% CI = -1.41, 0.13) OR TO ALL ACTIVE CONTROL GROUPS, COHEN'S D -0.13 (95% CI = -0.49, 0.22). A SUB-ANALYSIS SHOWED THAT YOGA HAD A SIGNIFICANT EFFECT ON THE REDUCTION OF DEPRESSION COMPARED TO PSYCHOEDUCATION CONTROL GROUPS, COHEN'S D -0.52 (95% CI = -0.96, -0.08) BUT NOT TO OTHER ACTIVE CONTROL GROUPS, COHEN'S D 0.28 (95% CI = -0.07, 0.63) FOR STUDIES USING A FOLLOW-UP OF SIX MONTHS OR MORE, HATHA YOGA HAD NO EFFECT ON THE REDUCTION OF DEPRESSION COMPARED TO ACTIVE CONTROL GROUPS, COHEN'S D -0.14 (95% CI = -0.60, 0.33). REGARDING ANXIETY, HATHA YOGA HAD NO SIGNIFICANT EFFECT WHEN COMPARED TO ACTIVE CONTROL GROUPS, COHEN'S D -0.09 (95% CI = -0.47, 0.30). THE I2 AND Q-STATISTIC REVEALED HETEROGENEITY AMONGST COMPARISONS. QUALITATIVE ANALYSES SUGGEST SOME PROMISE OF HATHA YOGA FOR CHRONIC POPULATIONS. CONCLUSIONS: THE ABILITY TO DRAW FIRM CONCLUSIONS IS LIMITED BY THE NOTABLE HETEROGENEITY AND LOW QUALITY OF MOST OF THE INCLUDED STUDIES. WITH THIS CAVEAT IN MIND, THE RESULTS OF THE CURRENT META-ANALYSIS SUGGEST THAT HATHA YOGA DOES NOT HAVE EFFECTS ON ACUTE, CHRONIC AND/OR TREATMENT-RESISTANT MOOD AND ANXIETY DISORDERS COMPARED TO TREATMENT AS USUAL OR ACTIVE CONTROL GROUPS. HOWEVER, WHEN COMPARED TO PSYCHOEDUCATION, HATHA YOGA SHOWED MORE REDUCTIONS IN DEPRESSION. IT IS CLEAR THAT MORE HIGH-QUALITY STUDIES ARE NEEDED TO ADVANCE THE FIELD. 2018 11 232 23 A SYSTEMATIC REVIEW OF YOGA FOR MAJOR DEPRESSIVE DISORDER. BACKGROUND: THE PURPOSE OF THIS REVIEW WAS TO INVESTIGATE THE EFFICACY AND SAFETY OF YOGA INTERVENTIONS IN TREATING PATIENTS WITH MAJOR DEPRESSIVE DISORDER. METHODS: MEDLINE, SCOPUS, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH DECEMBER 2016. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO INACTIVE OR ACTIVE COMPARATORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WERE ELIGIBLE. PRIMARY OUTCOMES INCLUDED REMISSION RATES AND SEVERITY OF DEPRESSION. ANXIETY AND ADVERSE EVENTS WERE SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: SEVEN RCTS WITH 240 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS UNCLEAR FOR MOST RCTS. COMPARED TO AEROBIC EXERCISE, NO SHORT- OR MEDIUM-TERM GROUP DIFFERENCES IN DEPRESSION SEVERITY WAS FOUND. HIGHER SHORT-TERM DEPRESSION SEVERITY WAS FOUND FOR YOGA COMPARED TO ELECTRO-CONVULSIVE THERAPY; REMISSION RATES DID NOT DIFFER BETWEEN GROUPS. NO SHORT-TERM GROUP DIFFERENCES OCCURRED WHEN YOGA WAS COMPARED TO ANTIDEPRESSANT MEDICATION. CONFLICTING EVIDENCE WAS FOUND WHEN YOGA WAS COMPARED TO ATTENTION-CONTROL INTERVENTIONS, OR WHEN YOGA AS AN ADD-ON TO ANTIDEPRESSANT MEDICATION WAS COMPARED TO MEDICATION ALONE. ONLY TWO RCTS ASSESSED ADVERSE EVENTS AND REPORTED THAT NO TREATMENT-RELATED ADVERSE EVENTS WERE REPORTED. LIMITATIONS: FEW RCTS WITH LOW SAMPLE SIZE. CONCLUSIONS: THIS REVIEW FOUND SOME EVIDENCE FOR POSITIVE EFFECTS BEYOND PLACEBO AND COMPARABLE EFFECTS COMPARED TO EVIDENCE-BASED INTERVENTIONS. HOWEVER, METHODOLOGICAL PROBLEMS AND THE UNCLEAR RISK-BENEFIT RATIO PRECLUDE DEFINITIVE RECOMMENDATIONS FOR OR AGAINST YOGA AS AN ADJUNCT TREATMENT FOR MAJOR DEPRESSIVE DISORDER. LARGER AND ADEQUATELY POWERED RCTS USING NON-INFERIORITY DESIGNS ARE NEEDED. 2017 12 1519 33 IS YOGA EFFECTIVE FOR PAIN? A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. OBJECTIVE: THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A TREATMENT OPTION FOR ANY TYPE OF PAIN. METHOD: SEVEN DATABASES WERE SEARCHED FROM THEIR INCEPTION TO FEBRUARY 2011. RANDOMIZED CLINICAL TRIALS WERE CONSIDERED IF THEY INVESTIGATED YOGA IN PATIENTS WITH ANY TYPE OF PAIN AND IF THEY ASSESSED PAIN AS A PRIMARY OUTCOME MEASURE. THE 5-POINT JADAD SCALE WAS USED TO ASSESS METHODOLOGICAL QUALITY OF STUDIES. THE SELECTION OF STUDIES, DATA EXTRACTION AND QUALITY ASSESSMENT WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. RESULTS: TEN RANDOMIZED CLINICAL TRIALS (RCTS) MET THE INCLUSION CRITERIA. THEIR METHODOLOGICAL QUALITY RANGED BETWEEN 1 AND 4 ON THE JADAD SCALE. NINE RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN PAIN THAN VARIOUS CONTROL INTERVENTIONS SUCH AS STANDARD CARE, SELF CARE, THERAPEUTIC EXERCISES, RELAXING YOGA, TOUCH AND MANIPULATION, OR NO INTERVENTION. ONE RCT FAILED TO PROVIDE BETWEEN GROUP DIFFERENCES IN PAIN SCORES. CONCLUSIONS: IT IS CONCLUDED THAT YOGA HAS THE POTENTIAL FOR ALLEVIATING PAIN. HOWEVER, DEFINITIVE JUDGMENTS ARE NOT POSSIBLE. 2011 13 1077 41 EFFECTS OF YOGA ON PSYCHOLOGIC FUNCTION AND QUALITY OF LIFE IN WOMEN WITH BREAST CANCER: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVE: THE AIM OF THIS META-ANALYSIS WAS TO EVALUATE THE EFFECTS OF YOGA ON PSYCHOLOGIC FUNCTION AND QUALITY OF LIFE (QOL) IN WOMEN WITH BREAST CANCER. DESIGN: A SYSTEMATIC SEARCH OF PUBMED, EMBASE, THE COCHRANE LIBRARY, THE CHINESE BIOMEDICAL LITERATURE DATABASE, AND THE CHINESE DIGITAL JOURNALS FULL-TEXT DATABASE WAS CARRIED OUT. RANDOMIZED CONTROL TRIALS (RCTS) EXAMINING THE EFFECTS OF YOGA, VERSUS A CONTROL GROUP RECEIVING NO INTERVENTION, ON PSYCHOLOGIC FUNCTIONING AND QOL IN WOMEN WITH BREAST CANCER WERE INCLUDED. METHODOLOGICAL QUALITY OF INCLUDED RCTS WAS ASSESSED ACCORDING TO THE COCHRANE HANDBOOK FOR SYSTEMATIC REVIEWS OF INTERVENTIONS 5.0.1, AND DATA WERE ANALYZED USING THE COCHRANE COLLABORATION'S REVIEW MANAGER 5.1. RESULTS: SIX (6) STUDIES INVOLVING 382 PATIENTS WERE INCLUDED. THE META-ANALYSIS SHOWED THAT YOGA CAN IMPROVE QOL FOR WOMEN WITH BREAST CANCER. A STATISTICALLY SIGNIFICANT EFFECT FAVORING YOGA FOR THE OUTCOME OF QOL WAS FOUND (STANDARD MEAN DIFFERENCE=0.27, 95% CONFIDENCE INTERVAL [0.02, 0.52], P=0.03). ALTHOUGH THE EFFECTS OF YOGA ON PSYCHOLOGIC FUNCTION OUTCOMES--SUCH AS ANXIETY, DEPRESSION, DISTRESS AND SLEEP--WERE IN THE EXPECTED DIRECTION, THESE EFFECTS WERE NOT STATISTICALLY SIGNIFICANT (P>0.05). FATIGUE SHOWED NO SIGNIFICANT DIFFERENCE (P>0.05). CONCLUSIONS: THE PRESENT DATA PROVIDED LITTLE INDICATION OF HOW EFFECTIVE YOGA MIGHT BE WHEN THEY WERE APPLIED BY WOMEN WITH BREAST CANCER EXCEPT FOR MILDLY EFFECTIVE IN QOL IMPROVEMENT. THE FINDINGS WERE BASED ON A SMALL BODY OF EVIDENCE IN WHICH METHODOLOGICAL QUALITY WAS NOT HIGH. FURTHER WELL-DESIGNED RCTS WITH LARGE SAMPLE SIZE ARE NEEDED TO CLARIFY THE UTILITY OF YOGA PRACTICE FOR THIS POPULATION. 2012 14 2568 36 YOGA FOR DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: MIND-BODY MEDICAL INTERVENTIONS ARE COMMONLY USED TO COPE WITH DEPRESSION AND YOGA IS ONE OF THE MOST COMMONLY USED MIND-BODY INTERVENTIONS. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR DEPRESSION. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, PSYCINFO, AND INDMED WERE SEARCHED THROUGH JANUARY 2013. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA FOR PATIENTS WITH DEPRESSIVE DISORDERS AND INDIVIDUALS WITH ELEVATED LEVELS OF DEPRESSION WERE INCLUDED. MAIN OUTCOMES WERE SEVERITY OF DEPRESSION AND REMISSION RATES, SECONDARY OUTCOMES WERE ANXIETY, QUALITY OF LIFE, AND SAFETY. RESULTS: TWELVE RCTS WITH 619 PARTICIPANTS WERE INCLUDED. THREE RCTS HAD LOW RISK OF BIAS. REGARDING SEVERITY OF DEPRESSION, THERE WAS MODERATE EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA COMPARED TO USUAL CARE (STANDARDIZED MEAN DIFFERENCE (SMD) = -0.69; 95% CONFIDENCE INTERVAL (CI) -0.99, -0.39; P < .001), AND LIMITED EVIDENCE COMPARED TO RELAXATION (SMD = -0.62; 95%CI -1.03, -0.22; P = .003), AND AEROBIC EXERCISE (SMD = -0.59; 95% CI -0.99, -0.18; P = .004). LIMITED EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS OF YOGA ON ANXIETY COMPARED TO RELAXATION (SMD = -0.79; 95% CI -1.3, -0.26; P = .004). SUBGROUP ANALYSES REVEALED EVIDENCE FOR EFFECTS IN PATIENTS WITH DEPRESSIVE DISORDERS AND IN INDIVIDUALS WITH ELEVATED LEVELS OF DEPRESSION. DUE TO THE PAUCITY AND HETEROGENEITY OF THE RCTS, NO META-ANALYSES ON LONG-TERM EFFECTS WERE POSSIBLE. NO RCT REPORTED SAFETY DATA. CONCLUSIONS: DESPITE METHODOLOGICAL DRAWBACKS OF THE INCLUDED STUDIES, YOGA COULD BE CONSIDERED AN ANCILLARY TREATMENT OPTION FOR PATIENTS WITH DEPRESSIVE DISORDERS AND INDIVIDUALS WITH ELEVATED LEVELS OF DEPRESSION. 2013 15 2597 29 YOGA FOR MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. WHILE YOGA SEEMS TO BE EFFECTIVE IN A NUMBER OF NEUROPSYCHIATRIC DISORDERS, THE EVIDENCE OF EFFICACY IN MULTIPLE SCLEROSIS REMAINS UNCLEAR. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE AVAILABLE DATA ON EFFICACY AND SAFETY OF YOGA IN PATIENTS WITH MULTIPLE SCLEROSIS. MEDLINE/PUBMED, SCOPUS, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, PSYCINFO, CAM-QUEST, CAMBASE, AND INDMED WERE SEARCHED THROUGH MARCH 2014. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA FOR PATIENTS WITH MULTIPLE SCLEROSIS WERE INCLUDED IF THEY ASSESSED HEALTH-RELATED QUALITY OF LIFE, FATIGUE, AND/OR MOBILITY. MOOD, COGNITIVE FUNCTION, AND SAFETY WERE DEFINED AS SECONDARY OUTCOME MEASURES. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. SEVEN RCTS WITH A TOTAL OF 670 PATIENTS WERE INCLUDED. EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA COMPARED TO USUAL CARE WERE FOUND FOR FATIGUE (STANDARDIZED MEAN DIFFERENCE [SMD] = -0.52; 95% CONFIDENCE INTERVALS (CI) = -1.02 TO -0.02; P = 0.04; HETEROGENEITY: I2 = 60%; CHI2 = 7.43; P = 0.06) AND MOOD (SMD = -0.55; 95%CI = -0.96 TO -0.13; P = 0.01; HETEROGENEITY: I2 = 0%; CHI2 = 1.25; P = 0.53), BUT NOT FOR HEALTH-RELATED QUALITY OF LIFE, MUSCLE FUNCTION, OR COGNITIVE FUNCTION. THE EFFECTS ON FATIGUE AND MOOD WERE NOT ROBUST AGAINST BIAS. NO SHORT-TERM OR LONGER TERM EFFECTS OF YOGA COMPARED TO EXERCISE WERE FOUND. YOGA WAS NOT ASSOCIATED WITH SERIOUS ADVERSE EVENTS. IN CONCLUSION, SINCE NO METHODOLOGICAL SOUND EVIDENCE WAS FOUND, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH MULTIPLE SCLEROSIS. YOGA MIGHT BE CONSIDERED A TREATMENT OPTION FOR PATIENTS WHO ARE NOT ADHERENT TO RECOMMENDED EXERCISE REGIMENS. 2014 16 308 33 AN EVIDENCE MAP OF YOGA FOR LOW BACK PAIN. OBJECTIVE: YOGA IS BEING INCREASINGLY STUDIED AS A TREATMENT STRATEGY FOR A VARIETY OF DIFFERENT CLINICAL CONDITIONS, INCLUDING LOW BACK PAIN (LBP). WE SET OUT TO CONDUCT AN EVIDENCE MAP OF YOGA FOR THE TREATMENT, PREVENTION AND RECURRENCE OF ACUTE OR CHRONIC LOW BACK PAIN (CLBP). METHODS: WE SEARCHED MEDLINE, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, EMBASE, ALLIED AND COMPLEMENTARY MEDICINE DATABASE AND CLINICALTRIALS.GOV FOR RANDOMIZED CONTROLLED TRIALS (RCT), SYSTEMATIC REVIEWS OR PLANNED STUDIES ON THE TREATMENT OR PREVENTION OF ACUTE BACK PAIN OR CLBP. TWO INDEPENDENT REVIEWERS SCREENED PAPERS FOR INCLUSION, EXTRACTED DATA AND ASSESSED THE QUALITY OF INCLUDED STUDIES. RESULTS: THREE ELIGIBLE SYSTEMATIC REVIEWS WERE IDENTIFIED THAT INCLUDED 10 RCTS (N=956) THAT EVALUATED YOGA FOR NON-SPECIFIC CLBP. WE DID NOT IDENTIFY ADDITIONAL RCTS BEYOND THOSE INCLUDED IN THE SYSTEMATIC REVIEWS. OUR SEARCH OF CLINICALTRIALS.GOV IDENTIFIED ONE SMALL (N=10) UNPUBLISHED TRIAL AND ONE LARGE (N=320) PLANNED CLINICAL TRIAL. THE MOST RECENT GOOD QUALITY SYSTEMATIC REVIEW INDICATED SIGNIFICANT EFFECTS FOR SHORT- AND LONG-TERM PAIN REDUCTION (N=6 TRIALS; STANDARDIZED MEAN DIFFERENCE [SMD] -0.48; 95% CI, -0.65 TO -0.31; I(2)=0% AND N=5; SMD -0.33; 95% CI, -0.59 TO -0.07; I(2)=48%, RESPECTIVELY). LONG-TERM EFFECTS FOR BACK SPECIFIC DISABILITY WERE ALSO IDENTIFIED (N=5; SMD -0.35; 95% CI, -0.55 TO -0.15; I(2)=20%). NO STUDIES WERE IDENTIFIED EVALUATING YOGA FOR PREVENTION OR TREATMENT OF ACUTE LBP. CONCLUSION: EVIDENCE SUGGESTS BENEFIT OF YOGA IN MIDLIFE ADULTS WITH NON-SPECIFIC CLBP FOR SHORT- AND LONG-TERM PAIN AND BACK-SPECIFIC DISABILITY, BUT THE EFFECTS OF YOGA FOR HEALTH-RELATED QUALITY OF LIFE, WELL- BEING AND ACUTE LBP ARE UNCERTAIN. WITHOUT ADDITIONAL STUDIES, FURTHER SYSTEMATIC REVIEWS ARE UNLIKELY TO BE INFORMATIVE. 2016 17 2079 32 THE EFFECT OF EXERCISE, YOGA AND PHYSIOTHERAPY ON THE QUALITY OF LIFE OF PEOPLE WITH MULTIPLE SCLEROSIS: SYSTEMATIC REVIEW AND META-ANALYSIS. INTRODUCTION: MULTIPLE SCLEROSIS (MS) IS A CHRONIC AUTOIMMUNE DISEASE AFFECTING THE MYELINATED AXONS OF THE CENTRAL NERVOUS SYSTEM CAUSING NEUROLOGICAL DETERIORATION. PEOPLE LIVING WITH MS HAVE A POOR QUALITY OF LIFE (QOL) BECAUSE OF THE SYMPTOMS CAUSED BY THE DISEASE AND THERE ARE VARIOUS TYPES OF TREATMENTS TO MANAGE THE SYMPTOMS ASIDE FROM MEDICATION. OBJECTIVE: THIS META-ANALYSIS EXAMINES THE EFFECT OF EXERCISE, YOGA AND PHYSIOTHERAPY ON THE PHYSICAL, MENTAL AND SOCIAL QOL AMONG INDIVIDUALS LIVING WITH MS. SETTING: A SYSTEMATIC REVIEW WITH META-ANALYSIS WAS CONDUCTED USING PUBMED, MEDLINE, AND SCOPUS FROM 1990 TO 2017. THE STANDARD MEAN DIFFERENCE SCORES WERE COMPUTED IN EACH STUDY FOR THE DOMAINS OF PHYSICAL, MENTAL AND SOCIAL FUNCTIONING. RESULTS: EIGHTEEN STUDIES MET THE INCLUSION CRITERIA FOR THIS META-ANALYSIS. AEROBIC EXERCISE WAS EFFECTIVE IN IMPROVING SATISFACTION WITH PHYSICAL FUNCTIONING,D = 0.35 (95% CI = 0.08 TO 0.62), MENTAL FUNCTIONING D = 0.42 (95% CI = 0.11 TO 0.72), AND SOCIAL FUNCTIONING D = 0.42 (95% CI = 0.15 TO 0.69). PHYSIOTHERAPY WAS ALSO FOUND TO BE EFFECTIVE FOR PHYSICAL FUNCTIONING D = 0.50 (95% CI 0.19 TO 0.80), MENTAL FUNCTIONING D = 0.44 (95% CI 0.14 TO 0.75) AND SOCIAL FUNCTIONING D = 0.60 (95% CI 0.21 TO 0.90). HOWEVER YOGA AND COMBINATION OF EXERCISES DID NOT HAVE A SIGNIFICANT EFFECT ON ANY OF THE QOL DOMAINS. CONCLUSION: THESE FINDINGS SUGGEST THAT AEROBIC EXERCISE AND PHYSIOTHERAPY IMPROVES THE SATISFACTION OF MS PATIENTS WITH THEIR PHYSICAL, MENTAL AND SOCIAL FUNCTIONING AND MAY BE INCLUDED AS NORMAL PRACTICE IN THE TREATMENT OF MS. 2019 18 2742 35 YOGA PRACTICE FOR THE MANAGEMENT OF TYPE II DIABETES MELLITUS IN ADULTS: A SYSTEMATIC REVIEW. THE EFFECT OF PRACTICING YOGA FOR THE MANAGEMENT OF TYPE II DIABETES WAS ASSESSED IN THIS SYSTEMATIC REVIEW THROUGH SEARCHING RELATED ELECTRONIC DATABASES AND THE GREY LITERATURE TO THE END OF MAY 2007 USING OVID. ALL RANDOMIZED CONTROLLED CLINICAL TRIALS (RCTS) COMPARING YOGA PRACTICE WITH OTHER TYPE OF INTERVENTION OR WITH REGULAR PRACTICE OR BOTH, WERE INCLUDED REGARDLESS OF LANGUAGE OR TYPE OF PUBLICATION. EACH STUDY WAS ASSESSED FOR QUALITY BY TWO INDEPENDENT REVIEWERS. MEAN DIFFERENCE WAS USED FOR SUMMARIZING THE EFFECT OF EACH STUDY OUTCOMES WITH 95% CONFIDENCE INTERVALS. POOLING OF THE STUDIES DID NOT TAKE PLACE DUE TO THE WIDE CLINICAL VARIATION BETWEEN THE STUDIES. PUBLICATION BIAS WAS ASSESSED BY STATISTICAL METHODS. FIVE TRIALS WITH 363 PARTICIPANTS MET THE INCLUSION CRITERIA WITH MEDIUM TO HIGH RISK OF BIAS AND DIFFERENT INTERVENTION CHARACTERISTICS. THE STUDIES' RESULTS SHOW IMPROVEMENT IN OUTCOMES AMONG PATIENTS WITH DIABETES TYPE II. THESE IMPROVEMENTS WERE MAINLY AMONG SHORT TERM OR IMMEDIATE DIABETES OUTCOMES AND NOT ALL WERE STATISTICALLY SIGNIFICANT. THE RESULTS WERE INCONCLUSIVE AND NOT SIGNIFICANT FOR THE LONG-TERM OUTCOMES. NO ADVERSE EFFECTS WERE REPORTED IN ANY OF THE INCLUDED STUDIES. SHORT-TERM BENEFITS FOR PATIENTS WITH DIABETES MAY BE ACHIEVED FROM PRACTICING YOGA. FURTHER RESEARCH IS NEEDED IN THIS AREA. FACTORS LIKE QUALITY OF THE TRIALS AND OTHER METHODOLOGICAL ISSUES SHOULD BE IMPROVED BY LARGE RANDOMIZED CONTROL TRIALS WITH ALLOCATION CONCEALMENT TO ASSESS THE EFFECTIVENESS OF YOGA ON DIABETES TYPE II. A DEFINITIVE RECOMMENDATION FOR PHYSICIANS TO ENCOURAGE THEIR PATIENTS TO PRACTICE YOGA CANNOT BE REACHED AT PRESENT. 2010 19 2612 27 YOGA FOR RHEUMATIC DISEASES: A SYSTEMATIC REVIEW. OBJECTIVE: TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS AN ANCILLARY INTERVENTION IN RHEUMATIC DISEASES. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY AND INDMED WERE SEARCHED THROUGH FEBRUARY 2013. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA WITH CONTROL INTERVENTIONS IN PATIENTS WITH RHEUMATIC DISEASES WERE INCLUDED. TWO AUTHORS INDEPENDENTLY ASSESSED THE RISK OF BIAS USING THE COCHRANE BACK REVIEW GROUP RISK OF BIAS TOOL. THE QUALITY OF EVIDENCE AND THE STRENGTH OF THE RECOMMENDATION FOR OR AGAINST YOGA WERE GRADED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: EIGHT RCTS WITH A TOTAL OF 559 SUBJECTS WERE INCLUDED; TWO RCTS HAD A LOW RISK OF BIAS. IN TWO RCTS ON FM SYNDROME, THERE WAS VERY LOW EVIDENCE FOR EFFECTS ON PAIN AND LOW EVIDENCE FOR EFFECTS ON DISABILITY. IN THREE RCTS ON OA, THERE WAS VERY LOW EVIDENCE FOR EFFECTS ON PAIN AND DISABILITY. BASED ON TWO RCTS, VERY LOW EVIDENCE WAS FOUND FOR EFFECTS ON PAIN IN RA. NO EVIDENCE FOR EFFECTS ON PAIN WAS FOUND IN ONE RCT ON CTS. NO RCT EXPLICITLY REPORTED SAFETY DATA. CONCLUSION: BASED ON THE RESULTS OF THIS REVIEW, ONLY WEAK RECOMMENDATIONS CAN BE MADE FOR THE ANCILLARY USE OF YOGA IN THE MANAGEMENT OF FM SYNDROME, OA AND RA AT THIS POINT. 2013 20 2365 24 WALKING IS MORE EFFECTIVE THAN YOGA AT REDUCING SLEEP DISTURBANCE IN CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. THIS REVIEW AIMED TO DETERMINE WHETHER WALKING IS MORE EFFECTIVE THAN YOGA AT IMPROVING SLEEP DISTURBANCE IN CANCER PATIENTS. A SYSTEMATIC SEARCH OF RANDOMIZED CONTROLLED TRIALS WAS PERFORMED IN THE PUBMED, EMBASE, CINAHL, COCHRANE LIBRARY, CNKI, AIRITI LIBRARY, AND OTHER HEALTH-RELATED DATABASES. TWENTY-FIVE STUDIES WERE IDENTIFIED WITH A TOTAL OF 1918 PARTICIPANTS. THE PITTSBURGH SLEEP QUALITY INDEX WAS THE MOST COMMONLY USED OUTCOME MEASUREMENT TOOL, AND MODERATE-INTENSITY WALKING WAS THE MOST FREQUENTLY USED INTERVENTION. THE MAJORITY OF THE INCLUDED SUBJECTS WERE BREAST CANCER PATIENTS. OVERALL, WALKING SIGNIFICANTLY IMPROVED SLEEP DISTURBANCE COMPARED TO YOGA (P = 0.01). STATISTICALLY SIGNIFICANT MODERATORS INCLUDED ADHERENCE RATE FOR WALKING (P < 0.001) AND ALLOCATION CONCEALMENT AND OUTCOME MEASUREMENT TOOL FOR YOGA (P = 0.04; P = 0.03). WE CONCLUDED THAT WALKING IS MORE EFFECTIVE THAN YOGA IN IMPROVING SLEEP DISTURBANCE IN CANCER PATIENTS. THUS, MODERATE-INTENSITY WALKING IS RECOMMENDED FOR CANCER PATIENTS WITH SLEEP DISTURBANCE. 2019